We report a case of a 64-year-old male patient with PD-L1-positive recurrent lung adenocarcinoma who developed hematochezia and diarrhea eight weeks after initiating pembrolizumab, leading to a diagnosis of irAE colitis. The gene discussed is CD274; the disease is lung adenocarcinoma.